Riskpilot← Back to searchSign inGet full accessSf-cliniken Oy
OYActiveY-tunnus 2460868-6Kirkonmäentie 14-BBeauty care and other beauty treatment activities · NACE 9622Est. 2012— employees
Revenue 2024
EUR 0
EBITDA margin
—
-97% vs 2023
Equity ratio
30.3%
Financial strength
Net profit 2024
EUR -89K
-156% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR 7K | -97% |
| Net profit | EUR -89K | -156% |
| Total assets | EUR 1,2M | +15% |
| Equity | EUR 369K | -26% |
| Employees | — | — |
Legal name
Sf-cliniken Oy
Y-tunnus number
2460868-6
Legal form
Osakeyhtiö
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
8. helmikuuta 2012
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on naisten ja miesten kauneudenhoitoon sekä terveyden- ja sairaudenhoitoon liittyvien erilaisten tuotteiden ja palveluiden tarjoaminen yleisölle. Yhtiö voi toimintaansa varten omistaa ja hallita osakehuoneistoja, kiinteistöjä, arvopapereita ja osuuksia sekä harjoittaa rakennusten käyttöoikeuden vuokraamista.
Address
Kirkonmäentie 14-B
Phone
+3580400974496
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 646 | 760 | 998 | 1 141 | 0 |
| Staff expenses | −392 | −421 | −497 | −566 | −566 |
| EBITDA | 36 | 127 | 260 | 276 | 7 |
| Depreciation & amort. | −34 | −54 | −43 | −52 | −65 |
| EBIT | 3 | 73 | 217 | 224 | −58 |
| Net financials | −26 | −25 | −20 | −23 | −32 |
| Profit before tax | −24 | 48 | 197 | 201 | −89 |
| Tax | −1 | −0 | 39 | 41 | −0 |
| Net profit | −23 | 48 | 158 | 160 | −89 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 017 | 1 046 | 1 050 | 1 062 | 1 219 |
| Equity | 160 | 208 | 367 | 498 | 369 |
| Long-term debt | 644 | 427 | 221 | 184 | 307 |
| Short-term debt | 212 | 411 | 462 | 380 | 543 |
| Total debt | 856 | 838 | 683 | 564 | 850 |
EBITDA margin
699000.0%
This company
15.8%
Market median
+4423951% vs market
20202024
Equity ratio
30.3%
This company
38.2%
Market median
+21% vs market
20202024
Return on equity
-24.2%
This company
18.4%
Market median
-232% vs market
20202024
Net profit margin
-8947500.0%
This company
8.1%
Market median
-110463063% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.30×
This company
0.62×
Market median
-271% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JE Chief Executive Officer | Chief Executive Officer | 2012 |
TM Deputy Member | Deputy Member | 2012 |
JT Deputy auditor | Deputy auditor | 2025 |
JA Audit | Audit | 2025 |
| Former (2) | ||
ET Audit | Audit | 2019 – 2025 |
AI Audit | Audit | 2016 – 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sf-cliniken Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jaana Elisabet Saloniemi | Chief Executive Officer | 0 companies |
| Tuomo Mikael Heikkilä | Deputy Member | 0 companies |
| Jari Tapani Nurkkala | Deputy auditor | 0 companies |
| Enni Tuulikki Isto | Audit | 0 companies |
| Janne Antero Kulju | Audit | 0 companies |
| Aarne Ilmari Pohjola | Audit | 0 companies |